Ubiquitin C-terminal hydrolase L1 is a regulator of tumor growth and metastasis in double-negative prostate cancer
American Journal of Clinical and Experimental Urology · 2024 · 12 (5) · 306-322
DOI: 10.62347/jnbr1463 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Clinical and Experimental Urology, 2024. Verfasst von Shiqin Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Medical Pharmacology, University of California, Los Angeles Los Angeles, CA, USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular and Medical Pharmacology, University of California, Los Angeles Los Angeles, CA, USA.
- Department of Radiology, Stanford University Palo Alto, CA, USA.
- Department of Urology, University of California, Los Angeles Los Angeles, CA, USA.
Förderung
- NCI NIH HHS
Zitieren
APA
Liu, S., Garcia-Marques, F. J., Shen, M., Bermudez, A., Pitteri, S. J., & Stoyanova, T. (2024). Ubiquitin C-terminal hydrolase L1 is a regulator of tumor growth and metastasis in double-negative prostate cancer. American Journal of Clinical and Experimental Urology, 12(5), 306-322. https://doi.org/10.62347/jnbr1463
Vancouver
Liu S, Garcia-Marques FJ, Shen M, Bermudez A, Pitteri SJ, Stoyanova T. Ubiquitin C-terminal hydrolase L1 is a regulator of tumor growth and metastasis in double-negative prostate cancer. American Journal of Clinical and Experimental Urology. 2024;12(5):306-322. doi:10.62347/jnbr1463
BibTeX
@article{Liu2024,
author = {Liu, Shiqin and Garcia-Marques, Fernando Jose and Shen, Michelle and Bermudez, Abel and Pitteri, Sharon J and Stoyanova, Tanya},
title = {Ubiquitin C-terminal hydrolase L1 is a regulator of tumor growth and metastasis in double-negative prostate cancer},
journal = {American Journal of Clinical and Experimental Urology},
year = {2024},
volume = {12},
number = {5},
pages = {306--322},
doi = {10.62347/jnbr1463}
}
EUVIMED